Nasdaq: AMRX
Amneal Pharmaceuticals insiders
The officers, directors and 10% owners of Amneal Pharmaceuticals, Inc. who hold the most stock, valued at the live AMRX price.
$21.39
AMRX today −$490K (−2.24%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 14
- Their AMRX stock
- $3.18B
- Market value
- $7.45B
- Held by ranked insiders
- 42.7%
Insiders by value of AMRX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Tushar Patel | 10% owner | 61,341,678 | $1.31B | 17.6% | 207th |
| 2 | Chintu Patel | Co-CEO | 29,332,640 | $627M | 8.42% | 404th |
| 3 | Dipan Patel | Insider | 26,905,073 | $575M | 7.72% | 441st |
| 4 | Chirag K. Patel | President & Co-CEO | 25,853,757 | $553M | 7.42% | 460th |
| 5 | Gautam Patel | Director | 1,927,595 | $41.2M | 0.55% | 2837th |
| 6 | Paul M. Meister | Director | 832,800 | $17.8M | 0.24% | 4501st |
| 7 | Tasos Konidaris | Executive Vice President & CFO | 449,434 | $9.6M | 0.13% | 9053rd |
| 8 | Jeffrey P. George | Director | 344,614 | $7.4M | <0.1% | 10705th |
| 9 | Joseph Todisco | Executive Vice President | 327,194 | $7.0M | <0.1% | 7987th |
| 10 | Ted C. Nark | Director | 325,848 | $7.0M | <0.1% | 11432nd |
| 11 | Shlomo Yanai | Director | 320,804 | $6.9M | <0.1% | 9703rd |
| 12 | J. Kevin Buchi | Director | 282,520 | $6.0M | <0.1% | 12088th |
| 13 | Nikita Shah | Executive Vice President | 253,390 | $5.4M | <0.1% | 13685th |
| 14 | Emily Peterson Alva | Director | 211,029 | $4.5M | <0.1% | 13113th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Amneal Pharmaceuticals; see each profile for the filing.